1 Product identity
Ingredient risk
No flagged ingredients

Antiox Max

BrandHoltraCeuticalsOther Combinations Capsule 11 ingredients DSLD #19248
Net contents: 120 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-05-24
2 Ingredients (11)
IngredientGroupSafety
Vitamin AVitamin A (unspecified)
Vitamin CVitamin CGenerally Safe
Vitamin EVitamin EConditionally Safe
SeleniumSeleniumConditionally Safe
N-Acetyl-L-CysteineN-Acetyl Cysteine
Green Tea extractGreen Tea
Lipoic AcidAlpha Lipoic Acid
QuercetinQuercetinConditionally Safe
ActiVinGrape
natural Vegetable Capsulescapsule
This product may contain one or more of the following:Header
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin A — Limited Evidence
⚠ Teratogenic at high doses
⚠ Hepatotoxic with chronic excess
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Selenium — Conditionally Safe
⚠ Selenosis >400 mcg
⚠ Diabetes risk at high doses
Green Tea Extract — Limited Evidence
⚠ HEPATOTOXICITY >800 mg EGCG
⚠ Iron absorption inhibition
Quercetin — Conditionally Safe
⚠ Inhibits CYP3A4
⚠ Affects cyclosporine levels
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID19248
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-05-24
6 More from HoltraCeuticals
View HoltraCeuticals Safety Scorecard → 48 products
Adrenal BoostAdrenal-CalmAge WellAloe 450Antiox MaxBig Hair
7 Cite this page
Vancouver
Pkhakadze G. Antiox Max — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/products/dsld-19248/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG